Intrinsiqq

Regional Health Properties, Inc. (RHEP) Quality Score

RHEP
Quality33

Weak across most dimensions. This doesn't mean avoid, but the burden of proof is on the bull case.

Broad-market heuristics · Not a buy/sell signal

Valuation

Growth

P/FFO Multiple
100/100
0.6x

0.6x FFO, reasonable REIT valuation

Revenue Growth
100/100
22.7%

Above 7% CAGR, strong REIT expansion

Business Quality & Capital Allocation

Share Dilution
0/100
121.2%

Heavy dilution above 5%

Debt / EBITDA
0/100
10.4x

10.4x EBITDA, high leverage

Interest Coverage
30/100
1.6x

1.6x coverage, tight

Valuation

Growth

P/FFO Multiple
100/100
0.6x

0.6x FFO, reasonable REIT valuation

Revenue Growth
100/100
22.7%

Above 7% CAGR, strong REIT expansion

Business Quality & Capital Allocation

Share Dilution
0/100
121.2%

Heavy dilution above 5%

Debt / EBITDA
0/100
10.4x

10.4x EBITDA, high leverage

Interest Coverage
30/100
1.6x

1.6x coverage, tight

Regional Health Properties (RHEP) quality: score, margins and returns

Regional Health Properties (RHEP) scores 33/100 on Intrinsiqq's quality score (a lower-quality business), a weighted blend of 5 metrics each scored 0 to 100, on 1.9% operating margins and 2.8% ROIC. Every metric is computed from SEC filings; this is analysis, not investment advice.

Frequently asked

Is Regional Health Properties (RHEP) a high-quality business?+

Regional Health Properties scores 33 out of 100 on Intrinsiqq's quality score, a weighted blend of 5 metrics each scored 0 to 100, which rates it a lower-quality business on these measures. Recent figures include a 1.9% operating margin and a 2.8% return on invested capital. Quality and price are separate questions: even a great business can be a poor investment if you overpay, so read this score alongside the valuation. The metric-by-metric breakdown is on this scorecard.

What does Regional Health Properties's quality score measure?+

Intrinsiqq's quality score weighs profitability, returns on capital, revenue growth, and balance-sheet strength, using measures suited to banks, insurers and other financial companies (where free-cash-flow and operating-margin metrics do not apply), each computed from RHEP's SEC filings rather than opinion or sentiment. A higher score means a more durable, capital-efficient business; it is not a buy or sell signal. Open each metric on this page to see exactly where Regional Health Properties scores well and where it falls behind.

What is Regional Health Properties's return on invested capital (ROIC)?+

Regional Health Properties earns about 2.8% on its invested capital, which is weak. ROIC measures how much profit a company generates per dollar put to work; sustained ROIC above its cost of capital is one of the clearest signs of a real competitive moat. Compare it to RHEP's margins and growth on this scorecard to judge durability.

How profitable is Regional Health Properties?+

Regional Health Properties runs an operating margin of about 1.9% and a net margin of about 4.7%. Revenue has grown at roughly 24.8% a year recently. High, stable margins usually point to pricing power and operating discipline. Margins are most telling next to growth and returns on capital, all of which feed this quality score. This is analysis from SEC filings, not investment advice.

SourceQuality score computed from the 10-Q filed 12 Aug 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 13 Aug 2026. How this is calculated.

Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically. Checks use broad-market heuristics, so sector norms may differ, and the valuation checks are more cyclical than the quality checks.

Related stocks: Lessors of Real Property, NEC

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.